Evaluation of serum concentrations of cortisol and sex hormones of adrenal gland origin after stimulation with two synthetic ACTH preparations in clinically normal dogs

Pedro J. Ginel Department of Animal Medicine and Surgery, Faculty of Veterinary Medicine, University of Córdoba, 14005 Córdoba, Spain.

Search for other papers by Pedro J. Ginel in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Maria T. Sileo Department of Animal Health, Faculty of Veterinary Medicine, University of Parma, 43126 Parma, Italy.

Search for other papers by Maria T. Sileo in
Current site
Google Scholar
PubMed
Close
 DVM
,
Beatriz Blanco Department of Animal Medicine and Surgery, Faculty of Veterinary Medicine, University of Córdoba, 14005 Córdoba, Spain.

Search for other papers by Beatriz Blanco in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Bartolomé Garfia Laboratorio Veterinario Garfia, Pol Tecnocórdoba, 14014 Córdoba, Spain.

Search for other papers by Bartolomé Garfia in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
, and
Fausto Quintavalla Department of Animal Health, Faculty of Veterinary Medicine, University of Parma, 43126 Parma, Italy.

Search for other papers by Fausto Quintavalla in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

Objective—To compare the adrenocortical response of healthy dogs to a commonly used dose of a nonadsorbed tetracosactide product (tetracosactide) with responses to 2 doses of a depot formulation of tetracosactide (depot tetracosactide).

Animals—14 dogs.

Procedures—Dogs were randomly assigned to receive tetracosactide (5 mg/kg, IV) or depot tetracosactide (250 μg, IM, or 5 μg/kg, IM). Dogs received each treatment once with a 2-week interval between treatments. Blood samples were assayed for cortisol, progesterone, 17-hydroxyprogesterone, androstenedione, and estradiol concentrations.

Results—Serum cortisol concentrations were significantly higher than the preadministration (baseline) concentrations for all treatments 60 minutes after administration of ACTH. Peak cortisol concentration was detected 180 minutes after IM administration of 250 μg of the depot tetracosactide. Serum concentrations of progesterone, 17-hydroxyprogesterone, and androstenedione did not differ significantly from baseline concentrations after stimulation with the 5 μg/kg dose of depot tetracosactide. Adrenal gland progesterone response was significantly higher than baseline concentrations at 60 minutes after administration of the 250-μg dose of depot tetracosactide, and the 17-hydroxyprogesterone and androstenedione responses were significantly higher than baseline concentrations at 120 minutes. Compared with the response to tetracosactide, adrenocortical response was higher and more sustained following administration of the depot tetracosactide, except for androstenedione concentration, which had a nonsignificant response.

Conclusions and Clinical Relevance—Except for androstenedione concentrations, a high dose of the depot tetracosactide (250 μg, IM) induced an adrenocortical response similar to that after administration of tetracosactide. Thus, depot tetracosactide may represent an alternative to the nonadsorbed tetracosactide product.

Abstract

Objective—To compare the adrenocortical response of healthy dogs to a commonly used dose of a nonadsorbed tetracosactide product (tetracosactide) with responses to 2 doses of a depot formulation of tetracosactide (depot tetracosactide).

Animals—14 dogs.

Procedures—Dogs were randomly assigned to receive tetracosactide (5 mg/kg, IV) or depot tetracosactide (250 μg, IM, or 5 μg/kg, IM). Dogs received each treatment once with a 2-week interval between treatments. Blood samples were assayed for cortisol, progesterone, 17-hydroxyprogesterone, androstenedione, and estradiol concentrations.

Results—Serum cortisol concentrations were significantly higher than the preadministration (baseline) concentrations for all treatments 60 minutes after administration of ACTH. Peak cortisol concentration was detected 180 minutes after IM administration of 250 μg of the depot tetracosactide. Serum concentrations of progesterone, 17-hydroxyprogesterone, and androstenedione did not differ significantly from baseline concentrations after stimulation with the 5 μg/kg dose of depot tetracosactide. Adrenal gland progesterone response was significantly higher than baseline concentrations at 60 minutes after administration of the 250-μg dose of depot tetracosactide, and the 17-hydroxyprogesterone and androstenedione responses were significantly higher than baseline concentrations at 120 minutes. Compared with the response to tetracosactide, adrenocortical response was higher and more sustained following administration of the depot tetracosactide, except for androstenedione concentration, which had a nonsignificant response.

Conclusions and Clinical Relevance—Except for androstenedione concentrations, a high dose of the depot tetracosactide (250 μg, IM) induced an adrenocortical response similar to that after administration of tetracosactide. Thus, depot tetracosactide may represent an alternative to the nonadsorbed tetracosactide product.

Contributor Notes

Supported by PAIDI Research Group BIO307.

Presented in part as a poster at the 20th European College of Veterinary Internal Medicine Companion Animal Congress, Toulouse, France, September 2010.

Address correspondence to Dr. Ginel (pginel@uco.es).
  • 1.

    Frank LA, Hnilica KA, Oliver JW. Adrenal steroid hormone concentrations in dogs with hair cycle arrest (alopecia X) before and during treatment with melatonin and mitotane. Vet Dermatol 2004; 15:278284.

    • Search Google Scholar
    • Export Citation
  • 2.

    Feldman EC, Nelson RW. Canine hyperadrenocorticism. In: Feldman EC, Nelson RW, eds. Canine and feline endocrinology and reproduction. 2nd ed. Philadelphia: WB Saunders Co, 2004;252357.

    • Search Google Scholar
    • Export Citation
  • 3.

    Watson ADJ, Church DB, Emslie DR, et al. Plasma-cortisol responses to 3 corticotropic preparations in normal dogs. Aust Vet J 1998; 76:255257.

    • Search Google Scholar
    • Export Citation
  • 4.

    Kerl ME, Peterson ME, Wallace MS, et al. Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism. J Am Vet Med Assoc 1999; 214:14971501.

    • Search Google Scholar
    • Export Citation
  • 5.

    Frank LA, DeNovo RC, Kraje AC, et al. Cortisol concentrations following stimulation of healthy and adrenopathic dogs with two doses of tetracosactrin. J Small Anim Pract 2000; 41:308311.

    • Search Google Scholar
    • Export Citation
  • 6.

    Frank LA, Davis JA, Oliver JW. Serum concentrations of cortisol, sex hormones of adrenal origin, and adrenocortical steroid intermediates in healthy dogs following stimulation with two doses of cosyntropin. Am J Vet Res 2004; 65:16311633.

    • Search Google Scholar
    • Export Citation
  • 7.

    Behrend EN, Kemppainen RJ, Bruyette DS, et al. Intramuscular administration of a low dose of ACTH for ACTH stimulation testing in dogs. J Am Vet Med Assoc 2006; 229:528530.

    • Search Google Scholar
    • Export Citation
  • 8.

    Nuvacthen depot [package insert]. Barcelona, Spain: Novartis Farmacéutica, 2009.

  • 9.

    Benitah N, Feldman EC, Kass PH, et al. Evaluation of serum 17-hydroxyprogesterone concentration after administration of ACTH in dogs with hyperadrenocorticism. J Am Vet Med Assoc 2005; 227:10951101.

    • Search Google Scholar
    • Export Citation
  • 10.

    Hill KE, Scott-Moncrieff CR, Koshko MA, et al. Secretion of sex hormones in dogs with adrenal dysfunction. J Am Vet Med Assoc 2005; 226:556561.

    • Search Google Scholar
    • Export Citation
  • 11.

    Frank LA, Rohrbach BW, Bailey EM, et al. Steroid hormone concentration profiles in healthy intact and neutered dogs before and after cosyntropin administration. Domest Anim Endocrinol 2003; 24:4357.

    • Search Google Scholar
    • Export Citation
  • 12.

    Reimers TJ, Salerno VJ, Lamb SV. Validation and application of solid-phase chemiluminescent immunoassays for diagnosis of endocrine diseases in animals. Comp Haematol Int 1996; 6:170175.

    • Search Google Scholar
    • Export Citation
  • 13.

    Immulite [package insert]. Caernarfon, Gwynedd, Wales. Siemens Medical Solutions, Diagnostics Ltd, 2009.

  • 14.

    17-α-OH progesterone EIA [package insert]. Barcelona, Spain: Radim Ibérica, 2006.

  • 15.

    Feldman EC, Stabenfeldt GH, Farver TB, et al. Comparison of aqueous porcine ACTH with synthetic ACTH in adrenal stimulations tests of the female dog. Am J Vet Res 1982; 43:522524.

    • Search Google Scholar
    • Export Citation
  • 16.

    Synacthen [package insert]. Origgio, Italy: Novartis Farma, 2004.

  • 17.

    Kemppainen RJ. Use of a low dose synthetic ACTH challenge test in normal and prednisone-treated dogs. Res Vet Sci 1983; 32:181183.

  • 18.

    Peterson ME, Kemppainen RJ. Dose-response relation between plasma concentrations of corticotropin and cortisol after administration of incremental doses of cosyntropin for corticotropin stimulation testing in cats. Am J Vet Res 1993; 54:300304.

    • Search Google Scholar
    • Export Citation
  • 19.

    Hansen BL, Kemppainen RJ, MacDonald JM. Synthetic ACTH (cosyntropin) stimulation tests in normal dogs: comparison of intravenous and intramuscular administration. J Am Anim Hosp Assoc 1994; 30:3841.

    • Search Google Scholar
    • Export Citation

Advertisement